| Typ : |
Labor |
|
| Forschungsgruppen : |
|
| Autoren : |
|
| Titel : |
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021 |
| Veröffentlichung : |
Sanofi Genzyme 2021 |
|
| Niveau von Beweisen : |
|
| physikalische Stabilität : |
|
| chemische Stabilität : |
|
| andere Verfahren : |
|
| Kommentare : |
|
Molekülverzeichnis
 Isatuximab
|
 |
 |
 |
 |
? mg/ml |
15-25°C |
 |
| 8 |
 |
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
 |
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
| |
+
|
|
|
|
|
| |
+
|
|
|
|
